Omega-3 Levels Measured after Coromega Supplementation
Coromega put an omega-3 product to the test, measuring blood omega-3 levels after patient supplementation.
Results of a trial on Coromega (Vista, CA) omega-3 fish oil suggest that the product can significantly increase omega-3 levels, as measured by the Holman Omega-3 Test.
As part of Coromega’s “6.2 for a Healthier You” campaign, 23 subjects were assigned to supplement with Coromega Omega-3 Squeeze and have their blood omega-3 levels assessed.
Blood omega-3 levels in the average American are estimated to be less than 5%, according to Coromega, which states that healthier levels start around 6%.
“Our preliminary findings have shown that people who take Coromega daily can achieve a score in the healthy omega-3 zone,” said Coromega scientific advisor Doug Bibus, PhD.
The Coromega product line is suitable for adults and children.
GC Rieber VivoMega uses AI platform from Intelecy to boost efficiency, quality, and sustainability
August 26th 2024According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
